HRT Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-716,826	Closed	-$5.59M	–	3820
2025 Q4	$5.59M	Buy	716,826 +658,920	+1,138%	+$4.76M	0.02%	735
2025 Q3	$439K	Sell	57,906 -66,714	-54%	-$556K	﹤0.01%	1957
2025 Q2	$1.12M	Buy	124,620 +66,551	+115%	+$620K	0.01%	1213
2025 Q1	$435K	Buy	+58,069	New	+$468K	﹤0.01%	1540
2024 Q4	–	Sell	-20,044	Closed	-$152K	–	2449
2024 Q3	$152K	Buy	+20,044	New	+$152K	﹤0.01%	2017
2024 Q1	–	Sell	-292,412	Closed	-$1.75M	–	2334
2023 Q4	$1.75M	Buy	292,412 +79,714	+37%	+$462K	0.01%	714
2023 Q3	$1.5M	Buy	212,698 +68,636	+48%	+$493K	0.02%	760
2023 Q2	$1.01M	Buy	144,062 +81,839	+132%	+$657K	0.01%	944
2023 Q1	$518K	Buy	+62,223	New	+$599K	0.01%	1353
2022 Q4	–	Sell	-23,803	Closed	-$299K	–	2477
2022 Q3	$299K	Buy	+23,803	New	+$306K	﹤0.01%	2002
2021 Q4	–	Sell	-126,125	Closed	-$1.81M	–	3199
2021 Q3	$1.81M	Buy	126,125 +7,575	+6%	+$119K	0.01%	809
2021 Q2	$1.87M	Buy	118,550 +78,720	+198%	+$1.07M	0.02%	659
2021 Q1	$405K	Sell	39,830 -261,852	-87%	-$2.7M	﹤0.01%	1939
2020 Q4	$2.25M	Buy	+301,682	New	+$1.56M	0.05%	300
2019 Q4	–	Sell	-77,424	Closed	-$221K	–	1155
2019 Q3	$221K	Buy	+77,424	New	+$241K	0.01%	1096
2015 Q3	–	Sell	-10,973	Closed	-$163K	–	90
2015 Q2	$163K	Buy	+10,973	New	+$125K	0.08%	127